These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30905703)

  • 1. Applications of In Silico Solvent Screening and an Interactive Web-Based Portal for Pharmaceutical Crystallization Process Development.
    Tan JS; Hilden LR; Merritt JM
    J Pharm Sci; 2019 Aug; 108(8):2621-2634. PubMed ID: 30905703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the solubility of pharmaceuticals in pure solvents and solvent mixtures for drug process design.
    Ruether F; Sadowski G
    J Pharm Sci; 2009 Nov; 98(11):4205-15. PubMed ID: 19283772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The construction, prediction and measurement of co-crystal ternary phase diagrams as a tool for solvent selection.
    Holaň J; Stěpánek F; Billot P; Ridvan L
    Eur J Pharm Sci; 2014 Oct; 63():124-31. PubMed ID: 24995701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a rational vs. high throughput approach for rapid salt screening and selection.
    Collman BM; Miller JM; Seadeek C; Stambek JA; Blackburn AC
    Drug Dev Ind Pharm; 2013 Jan; 39(1):29-38. PubMed ID: 22380522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational coformer or solvent selection for pharmaceutical cocrystallization or desolvation.
    Abramov YA; Loschen C; Klamt A
    J Pharm Sci; 2012 Oct; 101(10):3687-97. PubMed ID: 22821740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling and prediction of cocrystal phase diagrams.
    Ainouz A; Authelin JR; Billot P; Lieberman H
    Int J Pharm; 2009 Jun; 374(1-2):82-9. PubMed ID: 19446763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of pharmaceutical solubility Via NRTL-SAC and COSMO-SAC.
    Tung HH; Tabora J; Variankaval N; Bakken D; Chen CC
    J Pharm Sci; 2008 May; 97(5):1813-20. PubMed ID: 17786984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallization tendency of active pharmaceutical ingredients following rapid solvent evaporation--classification and comparison with crystallization tendency from undercooled melts.
    Van Eerdenbrugh B; Baird JA; Taylor LS
    J Pharm Sci; 2010 Sep; 99(9):3826-38. PubMed ID: 20533435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubility prediction, solvate and cocrystal screening as tools for rational crystal engineering.
    Loschen C; Klamt A
    J Pharm Pharmacol; 2015 Jun; 67(6):803-11. PubMed ID: 25851032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico prediction of drug solubility: 4. Will simple potentials suffice?
    Lüder K; Lindfors L; Westergren J; Nordholm S; Persson R; Pedersen M
    J Comput Chem; 2009 Sep; 30(12):1859-71. PubMed ID: 19115279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfluidic droplet liquid reactors for active pharmaceutical ingredient crystallization by diffusion controlled solvent extraction.
    Tona RM; McDonald TAO; Akhavein N; Larkin JD; Lai D
    Lab Chip; 2019 Jun; 19(12):2127-2137. PubMed ID: 31114833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
    Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
    Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
    Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
    Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Drivers of Crystallization Kinetics for Drugs in Supersaturated Aqueous Solutions.
    Alhalaweh A; Alzghoul A; Bergström CAS
    J Pharm Sci; 2019 Jan; 108(1):252-259. PubMed ID: 30423342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubility prediction of drugs in mixed solvents using partial solubility parameters.
    Jouyban A; Shayanfar A; Panahi-Azar V; Soleymani J; Yousefi BH; Acree WE; York P
    J Pharm Sci; 2011 Oct; 100(10):4368-82. PubMed ID: 21630276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing pharmaceutical crystallization in a flow crystallizer with ultrasound: Anti-solvent crystallization.
    Hussain MN; Jordens J; John JJ; Braeken L; Van Gerven T
    Ultrason Sonochem; 2019 Dec; 59():104743. PubMed ID: 31479884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of process analytical technology to crystallization processes.
    Yu LX; Lionberger RA; Raw AS; D'Costa R; Wu H; Hussain AS
    Adv Drug Deliv Rev; 2004 Feb; 56(3):349-69. PubMed ID: 14962586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New prediction methods for solubility parameters based on molecular sigma profiles using pharmaceutical materials.
    Niederquell A; Wyttenbach N; Kuentz M
    Int J Pharm; 2018 Jul; 546(1-2):137-144. PubMed ID: 29772285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High throughput screening: an in silico solubility parameter approach for lipids and solvents in SLN preparations.
    Shah M; Agrawal Y
    Pharm Dev Technol; 2013; 18(3):582-90. PubMed ID: 22107345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of co-crystal phase purity by mid infrared spectroscopy and multiple curve resolution.
    Queiroz ALP; Rodrigues M; Zeglinski J; Crean AM; Sarraguça MC; Vucen S
    Int J Pharm; 2021 Feb; 595():120246. PubMed ID: 33482224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.